These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

641 related items for PubMed ID: 27810187

  • 1. Impact of sodium oxybate, modafinil, and combination treatment on excessive daytime sleepiness in patients who have narcolepsy with or without cataplexy.
    Black J, Swick T, Bogan R, Lai C, Carter LP.
    Sleep Med; 2016 Aug; 24():57-62. PubMed ID: 27810187
    [Abstract] [Full Text] [Related]

  • 2. Sodium oxybate improves excessive daytime sleepiness in narcolepsy.
    Black J, Houghton WC.
    Sleep; 2006 Jul; 29(7):939-46. PubMed ID: 16895262
    [Abstract] [Full Text] [Related]

  • 3. Effect of sodium oxybate, modafinil, and their combination on disrupted nighttime sleep in narcolepsy.
    Dauvilliers Y, Roth T, Guinta D, Alvarez-Horine S, Dynin E, Black J.
    Sleep Med; 2017 Dec; 40():53-57. PubMed ID: 29221779
    [Abstract] [Full Text] [Related]

  • 4. Correlation between the Epworth Sleepiness Scale and the Maintenance of Wakefulness Test in patients with narcolepsy participating in two clinical trials of sodium oxybate.
    Erman M, Emsellem H, Black J, Mori F, Mayer G.
    Sleep Med; 2017 Oct; 38():92-95. PubMed ID: 29031763
    [Abstract] [Full Text] [Related]

  • 5. Sodium oxybate for narcolepsy with cataplexy: systematic review and meta-analysis.
    Alshaikh MK, Tricco AC, Tashkandi M, Mamdani M, Straus SE, BaHammam AS.
    J Clin Sleep Med; 2012 Aug 15; 8(4):451-8. PubMed ID: 22893778
    [Abstract] [Full Text] [Related]

  • 6. Once-nightly sodium oxybate (FT218) demonstrated improvement of symptoms in a phase 3 randomized clinical trial in patients with narcolepsy.
    Kushida CA, Shapiro CM, Roth T, Thorpy MJ, Corser BC, Ajayi AO, Rosenberg R, Roy A, Seiden D, Dubow J, Dauvilliers Y.
    Sleep; 2022 Jun 13; 45(6):. PubMed ID: 34358324
    [Abstract] [Full Text] [Related]

  • 7. The nightly administration of sodium oxybate results in significant reduction in the nocturnal sleep disruption of patients with narcolepsy.
    Black J, Pardi D, Hornfeldt CS, Inhaber N.
    Sleep Med; 2009 Sep 13; 10(8):829-35. PubMed ID: 19616998
    [Abstract] [Full Text] [Related]

  • 8. EFNS guidelines on management of narcolepsy.
    Billiard M, Bassetti C, Dauvilliers Y, Dolenc-Groselj L, Lammers GJ, Mayer G, Pollmächer T, Reading P, Sonka K, EFNS Task Force.
    Eur J Neurol; 2006 Oct 13; 13(10):1035-48. PubMed ID: 16987156
    [Abstract] [Full Text] [Related]

  • 9. Criteria for gauging response to sodium oxybate for narcolepsy.
    Steffen AD, Lai C, Weaver TE.
    J Sleep Res; 2018 Aug 13; 27(4):e12628. PubMed ID: 29205601
    [Abstract] [Full Text] [Related]

  • 10. A 2-week, polysomnographic, safety study of sodium oxybate in obstructive sleep apnea syndrome.
    George CF, Feldman N, Zheng Y, Steininger TL, Grzeschik SM, Lai C, Inhaber N.
    Sleep Breath; 2011 Jan 13; 15(1):13-20. PubMed ID: 20082240
    [Abstract] [Full Text] [Related]

  • 11. A 12-week open-label, multicenter study evaluating the safety and patient-reported efficacy of sodium oxybate in patients with narcolepsy and cataplexy.
    Mamelak M, Swick T, Emsellem H, Montplaisir J, Lai C, Black J.
    Sleep Med; 2015 Jan 13; 16(1):52-8. PubMed ID: 25533539
    [Abstract] [Full Text] [Related]

  • 12. Time to response with sodium oxybate for the treatment of excessive daytime sleepiness and cataplexy in patients with narcolepsy.
    Bogan RK, Roth T, Schwartz J, Miloslavsky M.
    J Clin Sleep Med; 2015 Apr 15; 11(4):427-32. PubMed ID: 25580605
    [Abstract] [Full Text] [Related]

  • 13. Changes in Cataplexy Frequency in a Clinical Trial of Lower-Sodium Oxybate with Taper and Discontinuation of Other Anticataplectic Medications.
    Dauvilliers Y, Šonka K, Bogan RK, Partinen M, Del Rio Villegas R, Foldvary-Schaefer N, Skowronski R, Chen A, Black J, Skobieranda F, Thorpy MJ.
    CNS Drugs; 2022 Jun 15; 36(6):633-647. PubMed ID: 35635687
    [Abstract] [Full Text] [Related]

  • 14. Comparing Treatment Effect Measurements in Narcolepsy: The Sustained Attention to Response Task, Epworth Sleepiness Scale and Maintenance of Wakefulness Test.
    van der Heide A, van Schie MK, Lammers GJ, Dauvilliers Y, Arnulf I, Mayer G, Bassetti CL, Ding CL, Lehert P, van Dijk JG.
    Sleep; 2015 Jul 01; 38(7):1051-8. PubMed ID: 25902810
    [Abstract] [Full Text] [Related]

  • 15. Narcolepsy: action of two gamma-aminobutyric acid type B agonists, baclofen and sodium oxybate.
    Huang YS, Guilleminault C.
    Pediatr Neurol; 2009 Jul 01; 41(1):9-16. PubMed ID: 19520267
    [Abstract] [Full Text] [Related]

  • 16. A randomized, double blind, placebo-controlled multicenter trial comparing the effects of three doses of orally administered sodium oxybate with placebo for the treatment of narcolepsy.
    Sleep; 2002 Feb 01; 25(1):42-9. PubMed ID: 11833860
    [Abstract] [Full Text] [Related]

  • 17. Long-Term Safety and Tolerability During a Clinical Trial and Open-Label Extension of Low-Sodium Oxybate in Participants with Narcolepsy with Cataplexy.
    Bogan RK, Foldvary-Schaefer N, Skowronski R, Chen A, Thorpy MJ.
    CNS Drugs; 2023 Apr 01; 37(4):323-335. PubMed ID: 36947322
    [Abstract] [Full Text] [Related]

  • 18. Sodium oxybate: new drug. Fewer attacks of cataplexy in some patients.
    Prescrire Int; 2007 Jun 01; 16(89):98-101. PubMed ID: 17582923
    [Abstract] [Full Text] [Related]

  • 19. Clinical and therapeutic aspects of childhood narcolepsy-cataplexy: a retrospective study of 51 children.
    Aran A, Einen M, Lin L, Plazzi G, Nishino S, Mignot E.
    Sleep; 2010 Nov 01; 33(11):1457-64. PubMed ID: 21102987
    [Abstract] [Full Text] [Related]

  • 20. Long-term safety and maintenance of efficacy of sodium oxybate in the treatment of narcolepsy with cataplexy in pediatric patients.
    Lecendreux M, Plazzi G, Dauvilliers Y, Rosen CL, Ruoff C, Black J, Parvataneni R, Guinta D, Wang YG, Mignot E.
    J Clin Sleep Med; 2022 Sep 01; 18(9):2217-2227. PubMed ID: 35689598
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 33.